Skip to main content

Osmetech to Use TriLink Reagents

NEW YORK (GenomeWeb News) — TriLink BioTechnologies will provide Osmetech Molecular Diagnostics with reagents for its new cystic fibrosis and warfarin sensitivity tests, TriLink said today.

TriLink said it will provide Osmetech with custom oligonucleotides required for its eSensor Cystic Fibrosis Carrier Detection System and its eSensor XT-8 System for warfarin sensitivity.

San Diego-based TriLink makes custom oligonucleotides, nucleoside triphosphates, and PCR products for the diagnostic and OEM markets.

Financial terms of the agreement were not released.

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.